Download PDF

Other users also viewed these articles

Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019 Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;
10.1016/j.aohep.2024.101757
Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease Eda Kaya; Eduardo Vilar-Gomez; Raj Vuppalanchi; Yusuf Yilmaz;
10.1016/j.aohep.2025.101907
Assessment of Metabolic dysfunction-associated steatotic liver disease, Alcohol-associated liver disease, and Metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population Jorge Emilio Lira-Vera; Ángel Daniel-Santana Vargas; Gabriela Gutiérrez-Reyes; Oscar Morales-Gutiérrez; María de Fátima Higuera-de la Tijera; Diana Montemira-Orozco; Christian Hinojosa-Segura; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María de los Ángeles Lemus-Peña; Daniel Montes de Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; Y.L. Béjar-Ramírez; José Luis Pérez-Hernández;
10.1016/j.aohep.2025.102149